Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: Implications for treatment of liver disease

American Journal of Pathology

Volumn 165, Issue 3, 2004, Pages 889-899

  Ward, Nicole L ^a,e   Haninec, Alexandra L ^a,b   Van Slyke, Paul ^a,b   Sled, John G ^a,b   Sturk, Celina ^a,b   Henkelman, R Mark ^a,b   Wanless, Ian R ^b,d   Dumont, Daniel J ^a,b,c  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; DNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS SHUNT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HEPATIC VEIN; LIVER CELL; LIVER DEVELOPMENT; LIVER DISEASE; MICROCIRCULATION; MOUSE; NONHUMAN; PHENOTYPE; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; TRANSGENIC MOUSE;

EID: 4344607995     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63351-2     Document Type: Article

References (54)

1. Huet PM, Villeneuve JP, Pomier-Layrargues G, Marleau D: Hepatic circulation in cirrhosis. Clin Gastroenterol 1985, 14:155-168
2. Wanless IR: Epithelioid hemangioendothelioma, multiple focal nodular hyperplasias, and cavernous hemangiomas of the liver. Arch Pathol Lab Med 2000, 124:1105-1107
3. Wanless IR, Mawdsley C, Adams R: On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985, 5:1194-1200
4. Wanless IR: Benign liver tumors. Clin Liver Dis 2002, 6:513-526
5. Tanaka M, Wanless IR: Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998, 27:488-496
6. DeLeve LD: Vascular liver diseases. Curr Gastroenterol Rep 2003, 5:63-70
7. Benyon RC, Iredale JP: Is liver fibrosis reversible? Gut 2000, 46:443-446
8. Wanless IR, Nakashima E, Sherman M: Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 2000, 124:1599-1607
9. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ: Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998, 102: 538-549
10. Ward NL, Dumont DJ: The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol 2002, 13:19-27
11. Veikkola T, Alitalo K: VEGFs, receptors and angiogenesis. Semin Cancer Biol 1999, 9:211-220
12. Mochida S, Ishikawa K, Inao M, Shibuya M, Fujiwara K: Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver. Biochem Biophys Res Commun 1996, 226:176-179
13. Assy N, Spira G, Paizi M, Shenkar L, Kraizer Y, Gehen T, Neufeld G, Dabbah B, Enat R, Baruch Y: Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats. J Hepatol 1999, 30:911-915
14. Ishikawa K, Mochida S, Mashiba S, Inao M, Matsui A, Ikeda H, Ohno A, Shibuya M, Fujiwara K: Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. Biochem Biophys Res Commun 1999, 254:587-593
15. Rosmorduc O, Wendum D, Corpechot C, Galy B, Sebbagh N, Raleigh J, Housset C, Poupon R: Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 1999, 155:1065-1073
16. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, Nabika T, Nagasue N: Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 1998, 27:1554-1562
17. Kondo F: Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol 2001, 16:1319-1328
18. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994, 8:1897-1909
19. Nourhaghighi N, Teichert-Kuliszewska K, Davis J, Stewart DJ, Nag S: Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab Invest 2003, 83:1211-1222
20. Ross MA, Sander CM, Kleeb TB, Watkins SC, Stolz DB: Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. Hepatology 2001, 34: 1135-1148
21. Sato T, El-Assal ON, Ono T, Yamanoi A, Dhar DK, Nagasue N: Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver. J Hepatol 2001, 34:690-698
22. Kraizer Y, Mawasi N, Seagal J, Paizi M, Assy N, Spira G: Vascular endothelial growth factor and angiopoietin in liver regeneration. Biochem Biophys Res Commun 2001, 287:209-215
23. Tanaka S, Sugimachi K, Yamashita Yi Y, Ohga T, Shirabe K, Shimada M, Wands JR: Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma. Hepatology 2002, 35:861-867
24. Dhar DK, Naora H, Yamanoi A, Ono T, Kohno H, Otani H, Nagasue N: Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: a comparison with angiopoietin/Tie pathway. Anticancer Res 2002, 22:379-386
25. Tanaka S, Mori M, Sakamoto Y, Makuuchi M, Sugimachi K, Wands JR: Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest 1999, 103:341-345
26. Kuroda H, Ohtsuru A, Futakuchi M, Kawashita Y, Nagayama Y, Fukuda E, Namba H, Shirai T, Kanematsu T, Yamashita S: Distinctive gene expression of receptor-type tyrosine kinase families during rat hepatocarcinogenesis. Int J Mol Med 2002, 9:473-480
27. Paradis V, Biáeche I, Dargáere D, Laurendeau I, Nectoux J, Degott C, Belghiti J, Vidaud M, Bedossa P: A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 2003, 124:651-659
28. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS: Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001, 294:559-563
29. Bahary N, Zon LI: Development. Endothelium-chicken soup for the endoderm. Science 2001, 294:530-531
30. Greene AK, Wiener S, Puder M, Yoshida A, Shi B, Perez-Atayde AR, Efstathiou JA, Holmgren L, Adamis AP, Rupnick M, Folkman J, O'Reilly MS: Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg 2003, 237:530-535
31. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, Ferrara N: Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003, 299:890-893
32. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lèubbert H, Bujard H: Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996, 93:10933-10938
33. Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, Carmeliet P, Goelman G, Keshet E: Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 2002, 21:1939-1947
34. Ward NL, Van Slyke P, Sturk C, Cruz M, Dumont DJ: Angiopoietin 1 expression levels in the myocardium direct coronary vessel development. Dev Dyn 2004, 229:500-509
35. Sarao R, Dumont DJ: Conditional transgene expression in endothelial cells. Transgenic Res 1998, 7:421-427
36. Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP, Alitalo K, Dumont DJ, Yancopoulos GD, Stewart DJ: Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 2001, 49:659-670
37. Jones N, Master Z, Jones J, Bouchard D, Gunji Y, Sasaki H, Daly R, Alitalo K, Dumont DJ: Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 1999, 274:30896-30905
38. Jones N, Dumont DJ: The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene 1998, 17:1097-1108
39. Feldkamp LA, Davis LA, Kress JW: Practical cone-beam algorithm. J Opt Soc Am A 1984, 1:612-619
40. Adams RBL: Seeded region growing. IEEE Trans Pattern Analysis Mach Intell 1994, 16:641-647
41. Jones N, Voskas D, Master Z, Sarao R, Jones J, Dumont DJ: Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2001, 2:438-445
42. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60
43. Pichiule P, LaManna JC: Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxia. J Appl Physiol 2002, 93:1131-1139
44. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W: Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 1998, 8:529-532
45. Kim I, Kim HG, Moon SO, Chae SW, So JN, Koh KN, Ahn BC, Koh GY: Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res 2000, 86:952-959
46. Zhu WH, MacIntyre A, Nicosia RF: Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting. Am J Pathol 2002, 161:823-830
47. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD: Increased vascularization in mice over-expressing angiopoietin-1. Science 1998, 282:468-471
48. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM: Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514
49. Rangheard AS, Vilgrain V, Audet P, O'Toole D, Vullierme MP, Valla D, Belghiti J, Menu Y: Focal nodular hyperplasia inducing hepatic vein obstruction. Am J Roentgenol 2002, 179:759-762
50. Arrivāe L, Dahan H, Tubiana JM: Hepatic vein obstruction in a case of focal nodular hyperplasia. Am J Roentgenol 1999, 173:857
51. Haber M, Reuben A, Burrell M, Oliverio P, Salem RR, West AB: Multiple focal nodular hyperplasia of the liver associated with hemihypertrophy and vascular malformations. Gastroenterology 1995, 108:1256-1262
52. Wanless IR, Lentz JS, Roberts EA: Partial nodular transformation of liver in an adult with persistent ductus venosus. Review with hypothesis on pathogenesis. Arch Pathol Lab Med 1985, 109:427-432
53. Shimamatsu K, Wanless IR: Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997, 26:343-350
54. Wanless IR: Physioanatomic considerations. Schiffs Disease of the Liver. Edited by ER Schiff, WC Maddrey. Philadelphia, Lippincott-Raven, 2002, pp 3-37